United States Patent and Trademark Office
Home
|
Site Index
|
Search
|
Guides
|
Contacts
|
e
Business
|
eBiz alerts
|
News
|
Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0
Summary
Query:
Party Name contains all words: EYEPOINT PHARMACEUTICALS US, INC.
Number of results:
11
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
97724847
11/30/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
RETIVU
S#:
97724847
Eli Lilly and Company
97724835
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
DURAMAC
S#:
97724835
Novartis AG
97767088
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
DURAVUE
S#:
97767088
Novartis AG
98048453
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
DURVUE
S#:
98048453
Novartis AG
98048464
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
DURVIEW
S#:
98048464
Novartis AG
98073717
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
DURAVYU
S#:
98073717
Novartis AG
97724740
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
DURAVU
S#:
97724740
Novartis AG
97724877
11/27/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
RYVIZ
S#:
97724877
JOHNSON & JOHNSON
98048432
11/13/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
OPVUE
S#:
98048432
Indivior Inc.
97724775
11/13/2023
EyePoint Pharmaceuticals US, Inc.
Mark:
OPVU
S#:
97724775
Indivior Inc.
88167946
04/18/2019
EyePoint Pharmaceuticals US, Inc.
Mark:
YUTIQ
S#:
88167946
Merck Sharp & Dohme Corp.
Results as of 11/21/2024 02:26 PM
Search again
|
.
HOME
|
INDEX
|
SEARCH
|
e
BUSINESS
|
CONTACT US
|
PRIVACY POLICY